Homozygous HSD3B1(1245C) inheritance and poor outcomes in metastatic castration-resistant prostate cancer with abiraterone or enzalutamide: what does it mean?

被引:5
作者
Sharifi, Nima [1 ,2 ,3 ]
机构
[1] Cleveland Clin, Genitourinary Malignancies Res Ctr, Lerner Res Inst, Cleveland, OH 44106 USA
[2] Cleveland Clin, Dept Urol, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Hematol & Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
关键词
ANDROGEN-DEPRIVATION THERAPY; LINEAGE PLASTICITY; HSD3B1; GENOTYPE; METABOLISM;
D O I
10.1016/j.annonc.2020.06.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1103 / 1105
页数:3
相关论文
共 20 条
  • [1] [Anonymous], 2016, NATURE, DOI DOI 10.1038/NATURE17954
  • [2] [Anonymous], 2017, SCIENCE, DOI DOI 10.1126/SCIENCE.AAH4199
  • [3] [Anonymous], 2018, J CLIN INVEST, DOI DOI 10.1172/JCI98319
  • [4] [Anonymous], 2019, ENDOCRINOLOGY, DOI DOI 10.1210/EN.2019-00366
  • [5] [Anonymous], 2013, CELL, DOI DOI 10.1016/J.CELL.2013.07.029
  • [6] [Anonymous], 2020, JAMA ONCOL, DOI DOI 10.1001/JAMAONCOL.2020.0147
  • [7] [Anonymous], 2017, JAMA ONCOL, DOI DOI 10.1001/JAMAONCOL.2017.0147
  • [8] [Anonymous], 2018, J CLIN ONCOL
  • [9] [Anonymous], 2016, LANCET ONCOL, DOI DOI 10.1016/S1470-2045(16)30227-3
  • [10] [Anonymous], 2020, ANNU REV MED, DOI DOI 10.1146/ANNUREV-MED-051418-060357